THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The existing problem has uncovered some structural weaknesses within the EU’s medicines source chain and also a significant dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She advisable that supply chain troubles be tackled in an EU pharmaceutical strategy envisioned to get released by